HPV vaccine could drastically reduce cervical and other cancers globally

Cervical cancer affects more than half a million women and causes more than a quarter of a million deaths each year globally. Almost all cervical cancers result from a human papillomavirus, or HPV, infection. HPV infections cause cancers in other parts of the body, too. But the latest HPV vaccine could prevent most infections -- and millions of cancers -- worldwide, according to an article by Cosette Wheeler, PhD, and her collaborators.

The article describing the HPV vaccine and strategies to overcome issues with its use was published online by the American Society of Clinical Oncology. ASCO shared a print of the article with the 30,000 attendees at its Annual Meeting this year. Annual Meeting attendees included top oncologists from around the country and the world. Wheeler is an international HPV expert, a University of New Mexico Regents' Professor and a member of The University of New Mexico Comprehensive Cancer Center. She and the other authors of the article served as expert panel members for the Primary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline.

The HPV vaccine could prevent up to 90 percent of HPV-related cancers worldwide, according to the article. The authors report that women in high-income countries or regions are far more likely to survive a cervical cancer diagnosis. But even within high-income countries, those women in lower-income regions get cervical cancer more frequently and fewer of them survive it. And, this disparity applies to other HPV-related cancers in women and men, including other genital cancers, anal cancers, and cancers of the mouth and throat.

The HPV vaccine can prevent HPV infection if the vaccine is given before exposure to any of the HPV types that the vaccine protects against. Different formulas of the HPV vaccine protect against different types of HPV. Only two types, HPV16 and HPV18, cause 70 percent or more of all invasive cervical cancers and all HPV vaccine formulas protect against these two. The nonavalent formula of the HPV vaccine is the most protective: it protects against HPV16, HPV18 and five other cancer-causing HPV types. As of June, 2017, only the nonavalent HPV vaccine is available in the United States.

Experts estimate that the nonavalent HPV vaccine could reduce HPV-related cancers worldwide by 90 percent or more if the entire global population received it. Several studies have shown the vaccine to be efficacious. Studies have also shown its benefits and its harms to be similar to many other vaccines that protect against infections.

Currently, though, global HPV vaccination rates are low. The vaccine must be given in two or three doses. This can prove difficult for teens and preteens who lack easy and affordable access to a clinic and who do not receive regular medical check-ups. The article suggests giving the HPV vaccine with other childhood vaccines as a critical strategy to lessen this burden. The article also cites studies that have shown two doses to be as protective as three doses if vaccination is started at a younger age. The United States Advisory Committee on Immunization Practices now recommends two doses of HPV vaccine for both boys and girls, but only if they receive their first HPV vaccine dose between ages 9 and 14. After a teen's fifteenth birthday, the Committee still recommends three HPV vaccine doses.

The article strongly recommends reaching out to parents, teachers, medical providers and other community members to encourage HPV vaccination among teens and preteens. Providers' support of using the HPV vaccine is linked to higher vaccination rates, the article states. The article goes on to say that providers' strong recommendation for HPV vaccination is therefore key to protecting global populations against HPV-related cancers.

"Cervical and other HPV-related cancers are preventable," says Wheeler. "We have the unprecedented opportunity to impact the global cancer burden and improve people's lives and health everywhere.

Story Source:
SD

Comments

Post a Comment

Popular posts from this blog

NEEM TREE & MEDICINAL USES

Image
NEEM TREE & MEDICINAL USES "Dogo Yarow" The TREE of LIFE The Magical Evergreen Tree The neem plant is native to India but gradually spread to many parts of the world over the years. IT HAS BEEN USED LOCALLY AS MEDICINE OVER THOUSANDS OF YEARS, AND OVER THE CENTURIES IN PHARMACEUTICALS, COSMETICS AND TOILETRIES. Almost every part of this wonder plant is Medicinal, ranging from roots, bark, twigs, leaves, flowers and seeds...... It's very common within the Hausa communities in Cameroon more especially in the Northen regions which predominantly occupied by the Hausa ethnic group. They call it Dogo Yarow which when translated means, TALL CHILD or TALL PIKIN in Pidgin English..... MEDICINAL USES OF THE TREE OF LIFE - NEEM: * Cardiac Problems: Infusions of leaves in HOT water when taken removes bad sugars and toxins from blood, dilates blood vessels, improves blood circulation and balances heart pumping rates * High Blood Pressure: It relaxes erratic heart beats a
Read more

TAPE WORMS: Unwanted 'Guests' in the Intestines

Image
https://m.facebook.com/story.php?story_fbid=261432537653223&id=193799827749828 Tapeworms are flat, segmented worms that live in the intestines of some animals. Animals can become infected with these parasites when grazing in pastures or drinking contaminated water. Eating undercooked meat from infected animals is the main cause of tapeworm infection in people. Although tapeworms in humans usually cause few symptoms and are easily treated, they can sometimes cause serious, life-threatening problems. That's why it's important to recognize the symptoms and know how to protect yourself and your family. Tapeworm Causes Six types of tapeworms are known to infect people. They are usually identified by the animals they come from -- for example, Taenia saginata from beef, Taenia solium from pork, and Diphyllobothrium latum from fish. Tapeworms have a three-stage lifecycle: egg, an immature stage called a larva, and an adult stage at which the worm can produce more eggs. Bec
Read more

8,260 students graduate as ABU holds 40th convocation tomorrow

Image
The 40th convocation ceremony of the Ahmadu Bello University (ABU), Zaria will hold tomorrow with 8,260 students graduating with first degrees. The Vice Chancellor of the university, Professor Ibrahim Garba, made this known during a press briefing yesterday, saying that the convocation would confirm the graduation of 256 PhD students. He said the number of PhD and about 3,600 other postgraduate graduands was a confirmation of the new status that ABU had assumed where priority was given to postgraduate studies. Professor Garba said ABU was expanding its carrying capacity through introduction of new programmes to accommodate more applicants who usually overwhelmed the school. “It is in this direction that we now allow more institutions to run degree programmes with our affiliation.  We have also introduced distance learning where we admit hundreds of students and we would commence undergraduate studies in the centre,” he said.
Read more